Parth Desai

Parth is a Principal at Flare Capital Partners.

Prior to joining Flare Capital, Parth was an investor at NewYork-Presbyterian (NYP) Ventures, responsible for venture investing, commercializing internal innovation and forming strategic partnerships to enhance the hospital’s patient and clinician care experience. At NYP, Parth primarily focused on applications of artificial intelligence to healthcare operations, leading the investment process for NYP’s investments in Saykara, Syllable and Workfusion.

Prior to joining NYP Ventures, Parth was a health care strategy consultant at Deloitte Consulting, responsible for developing corporate growth strategies, performing M&A due diligence and supporting operational transformations for leading providers, payers and technology companies. At Deloitte, he supported the creation of a tech-enabled managed services organization and a population health joint venture, while also advising a number of successful M&A transactions.

Parth began his career as health policy analyst for the Massachusetts House of Representatives, where he primarily worked with the Patrick administration to manage reform of the pharmaceutical compounding industry, authoring legislation signed into law by Governor Deval Patrick and used by the FDA to model national regulations.

​Parth earned his B.S. in Biology from Boston College, MPH in Health Policy and Management from Boston University School of Public Health and Masters in Medicine from Boston University School of Medicine.